SGP

30.8300.16%
JV

Jean-Frederic Viret

Chief Financial Officer

Dr. Jean-Frederic Viret, Ph.D., is Chief Financial Officer of SpyGlass Pharma, Inc. from January 6, 2026. He was Chief Financial Officer of NGM Bio Holdings, Inc. Dr. Viret served as Chief Financial Officer at Shasqi, Inc since February 2023. He served as Chief Financial Officer at Blade Therapeutics, Inc. since March 22, 2021. He had been the Chief Financial Officer of Coherus Biosciences, Inc. since September 2014 until March 7, 2021 and also served as its Principal Accounting Officer. Dr. Viret served as the Chief Financial Officer of diaDexus, Inc. from February 2012 to September 2014 and as its Principal Accounting Officer. He served as the Chief Financial Officer of XDx Inc. (now CareDx, Inc) from December 2009 to January 2012. He served as a Finance Consultant of Anesiva, Inc. from February 2009 to May 2009. From March 2009 to December 2009, Dr. Viret served as President of JV Consulting, a private consulting firm that provided accounting, public company compliance and other financial consulting services to technology companies. He served at Anesiva inc. (also known as Corgentech Inc.) since 2002. He served as Chief Financial Officer of Anesiva, Inc. from December 2002 to February 18, 2009. He served as Vice President of Finance of Anesiva Inc. from August 2006 to February 2008 and also served its Senior Director of Finance. He served as Vice President at Anesiva, Inc. from December 2002 to February 18, 2009 and served as its Principal Accounting Officer until February 18, 2009. Dr. Viret served as an Associate Director of Finance of Tularik (now Amgen) from March 2000 to November 2002 and Senior Associate of PricewaterhouseCoopers LLP from September 1997 to March 2000. He has served on the Board of trustees of the International School of the Peninsula in Palo Alto, California since September 2011. Dr. Viret has extensive corporate finance experience within the life sciences industry, most recently serving as CFO with Coherus BioSciences, Inc. (NASDAQ: CHRS), a commercial-stage biopharmaceutical company that he joined in 2014. He has previous experience in CFO roles during tenures at several public and privately held biopharmaceutical and diagnostics companies. He was a visiting Fellow in Molecular Biology at Harvard University. He is a Certified Public Accountant. He holds an MBA degree from the Johnson School at Cornell University, a Ph.D. degree in Molecular Biology from the University Louis Pasteur and B.S. in Engineering from the Institute National Polytechnique de Lorraine, he has a PhD in Plant Molecular Biology from the University of Strasbourg. Dr. Viret completed a Postdoctoral Fellowship in Molecular Biology at the Massachusetts Institute of Technology.

Positions